DCT

3:17-cv-07923

Boehringer Ingelheim Pharma Inc v. Hetero USA Inc

General
Filed
10/05/17
Cause of ActionInfringement
SectorBiotech
Status
Closed (08/28/19)
Patent Owner
NPE (W)
Judge
Period
PO Win Rate
--
57%